Contrast sensitivity improves after brimonidine therapy in primary open angle glaucoma: A case for neuroprotection

British Journal of Ophthalmology

Volumn 87, Issue 12, 2003, Pages 1463-1465

  Evans, D W ^b   Hosking, S L ^a   Gherghel, D ^a   Bartlett, J D ^b,c  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; TIMOLOL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; GLAUCOMA; HEART RATE; HUMAN; INTRAOCULAR PRESSURE; NEUROPROTECTION; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL FIELD;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; CONTRAST SENSITIVITY; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MIDDLE AGED; QUINOXALINES; RECEPTORS, ADRENERGIC, ALPHA-2; TIMOLOL;

EID: 0346887097     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.12.1463     Document Type: Article

References (17)

1. Flammer J, Orgül S. Optic nerve blood-flow abnormalities in glaucoma. Prog Ret Eye Res 1998;17:267-89.
2. Stamper RL. Psychophysical changes in glaucoma. Surv Ophthalmol 1989;33(suppl I):309-18.
3. Sample PA, Juang PS, Weinreb RN. Isolating the effects of primary open-angle glaucoma on the contrast sensitivity function. Am J Ophthalmol 1991;112:308-16.
4. Pomerance GN, Evans DW. Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci 1994;35:3357-61.
5. Gandolfi SA, Cionino L, Vecchi M. Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma. Acta Ophthalmol Scand Suppl 1997;224:40.
6. Curcio C, Allen K. Topography of ganglion cells in human retina. J Comp Neurol 1990;300:5-25.
7. Donello JE, Padilla EU, Webster ML, et al. Alpha(2)-adrenoreceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J Pharmacol Exp Ther 2001;296:216-23.
8. Hasson D, Lai R, Chun T, et al. Functional protection of rat retina from ischemic injury by brimonidine. Soc Neurosci Abstracts 1997;23:168.
9. Lai R, Chun T, Hasson D, et al. Activation of cell survival signaling pathway in the retina by selective alpha-2 adrenoreceptor agonist brimonidine. Invest Ophthalmol Vis Sci 1999;40(Suppl):S763.
10. Bylund DB, Chacko DM. Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates. Invest Ophthalmol Vis Sci 1999;40:2299-306.
11. Yoles E, Wheeler L, Schwartz M. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci 1999;40:65-73.
12. Wheeler LA, Lai R, Wolde-Mussie E. From the lab to the clinic: Activation of an alpha2 agonist pathway is neuroprotective in models of retinal and optic nerve injury. Eur J Ophthalmol 1999;9:S17-21.
13. Wolde-Mussie E, Ruiz G, Wijono M, et al. Neuroprotective effect of brimonidine in chronic ocular hypertensive rats. Invest Ophthalmol Vis Sci 2000;41:S830.
14. Wolde-Mussie E, Ruiz G, Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001;42:2849-55.
15. Evans DW, Harris A, Chung HS, et al. Effects of long-term hypotensive therapy with nonselective beta-blockers on ocular hemodynamics in primary open-angle glaucoma. J Glaucoma 1999;8:12-17.
16. Evans D, Harris A, Cantor LB. Primary open-angle glaucoma patients characterized by ocular vasospasm demonstrate a different ocular vascular response to timolol versus betaxolol. J Ocul Pharmacol Ther 1999;15:479-87.
17. Harris A, Evans DW, Cantor LB, et al. Hemodynamic and visual function effects of oral nifedipine in. Am J Ophthalmol 1997;124:296-302.